Cheaper, Generic Weight-Loss Drugs Are Coming
On today’s Big Take podcast: Novo Nordisk’s patents on Ozempic are starting to expire. What does that mean for the global weight-loss drug market?
By David Gura, David Fox, Rachael Lewis-Krisky · Bloomberg
On today’s Big Take podcast: Novo Nordisk’s patents on Ozempic are starting to expire. What does that mean for the global weight-loss drug market?